Abstract
Erythropoietin is an important drug for the treatment of anemia in hemodialysis patients. But there were many patients with erythropoietin-hyporesponsive. Roxadustat has been shown effective in treating patients with anemia due to chronic kidney disease. However, the efficacy and safety of roxadustat in hemodialysis patients with erythropoietin-hyporesponsive anemia remains unclear.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
